Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan
- PMID: 2940332
- DOI: 10.1002/jmv.1890180402
Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan
Abstract
Hepatitis B virus (HBV) markers were studied by radioimmunoassays in serum samples of 1,200 (647 male, 553 female) apparently healthy children under 15 years of age in Taipei between June and October 1984. The prevalence rate of hepatitis B surface antigen (HBsAg) was 5.1% in infancy, increased to 10.7% between 1 and 2 years of age, and then remained constant at about 10% thereafter. The prevalence rate of surface antibody (anti-HBs), core antibody (anti-HBc), and seropositivity (at least one marker of hepatitis B detectable) were 39.0, 30.5, and 52.5%, respectively, in infancy, then decreased to 10.7, 14.3, and 17.9%, respectively, between 1 and 2 years of age. Thereafter, the antibody prevalence increased in parallel with age. By the age of 13-14 years, nearly half of the children were infected by HBV. The results suggested that in our children, most HBsAg carriers resulted from infections before 3 years of age, and HBV infections after 3 years of age infrequently resulted in a carrier state. One hundred (83.3%) of the 120 HBsAg-positive children had hepatitis B e antigen (HBeAg), indicating high prevalence in young asymptomatic HBsAg carriers. The prevalence rate of HBeAg tended to decrease with age and a reversed trend was observed with anti-HBe. Our study, just before our government extends mass hepatitis B vaccination program from newborns to children, provides background seroepidemiologic data of HBV infections in the healthy children in Taiwan.
Similar articles
-
Hepatitis B e antigen and antibody in asymptomatic Chinese with hepatitis B surface antigenemia in Taiwan.Gastroenterol Jpn. 1982;17(4):341-6. doi: 10.1007/BF02774580. Gastroenterol Jpn. 1982. PMID: 7141198
-
Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.J Med Virol. 1986 May;19(1):87-94. doi: 10.1002/jmv.1890190113. J Med Virol. 1986. PMID: 3701304
-
The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.Vaccine. 2001 Jul 16;19(28-29):3919-26. doi: 10.1016/s0264-410x(01)00120-7. Vaccine. 2001. PMID: 11427266
-
[Natural routes of the spread of viral hepatitis B].Zh Mikrobiol Epidemiol Immunobiol. 1984 Feb;(2):12-7. Zh Mikrobiol Epidemiol Immunobiol. 1984. PMID: 6369837 Review. Russian. No abstract available.
-
Immunology of hepatitis B virus infections.Rheumatol Int. 1989;9(3-5):167-73. doi: 10.1007/BF00271875. Rheumatol Int. 1989. PMID: 2692126 Review.
Cited by
-
Intra-familial spread of hepatitis B virus infection in eastern Turkey.Epidemiol Infect. 2007 Nov;135(8):1338-43. doi: 10.1017/S0950268807008011. Epub 2007 Feb 21. Epidemiol Infect. 2007. PMID: 17313693 Free PMC article.
-
Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation.Hepatol Int. 2010 Dec 16;5(1):586-96. doi: 10.1007/s12072-010-9227-x. Hepatol Int. 2010. PMID: 21442057 Free PMC article.
-
Chronic viral hepatitis.Indian J Pediatr. 1995 Nov-Dec;62(6):673-9. doi: 10.1007/BF02825113. Indian J Pediatr. 1995. PMID: 10829942 Review.
-
Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma.Gut. 2003 Jan;52(1):122-5. doi: 10.1136/gut.52.1.122. Gut. 2003. PMID: 12477772 Free PMC article.
-
Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead.Viruses. 2020 Jul 28;12(8):815. doi: 10.3390/v12080815. Viruses. 2020. PMID: 32731536 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical